Financials
- Market Capitalization 299.81 M
- Employee 854
- Founded N/A
- CEO Gary S. Gillheeney Sr.
- Website www.organogenesis.com
- Headquarter Delaware, United States
- FIGI BBG00FGGD295
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-19.75
Relación precio/flujo de caja
0.6
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3116 | EBS Emergent BioSolutions Inc. Common Stock | 7.53 USD | +0.27% | -7.72% | -9.28% | -29.76% | 388.52 M USD | ||
| 3143 | AKBA Akebia Therapeutics, Inc. - Common Stock | 1.36 USD | -2.86% | -0.73% | +47.83% | +15.25% | 364.83 M USD | ||
| 3371 | TKNO Alpha Teknova, Inc. - Common Stock | 5.32 USD | -1.66% | +5.14% | +29.44% | +20.91% | 285.23 M USD | ||
| 3492 | SIGA SIGA Technologies Inc. - Common Stock | 3.47 USD | +1.46% | -3.88% | -19.86% | -59.18% | 248.88 M USD |